| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,445,552 | 4,430,626 | 8,186,033 | 8,363,150 | | Cost of Revenue | 3,029,510 | 2,198,598 | 7,020,079 | 7,152,044 | | | Gross Profit | 416,042 | 2,232,028 | 1,165,954 | 1,211,106 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 56,832 | 1,747,369 | 56,552 | 55,569 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 201,022 | 209,127 | 179,981 | 170,400 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 158,188 | 275,532 | 929,421 | 985,137 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (20,236) | 20,236 |
-
| | Earnings Before Interest And Taxes | 158,188 | 255,296 | 949,657 | 985,137 | | Interest Expense | 1,665 | (15,647) | 29,566 | 15,556 | | Income Before Tax | 156,523 | 270,943 | 920,091 | 969,581 | | Income Tax Expense | 85,283 | 143,575 | 335,669 | 350,377 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 71,240 | 127,368 | 584,422 | 619,204 | | | Non-recurring Events | | Discontinued Operations | 99,864 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 171,104 | 127,368 | 584,422 | 619,204 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $171,104 | $127,368 | $584,422 | $619,204 |
|
0.45% Nasdaq 
0.20%
Income Statement
